This article examines the necessity and methodologies for the cross-cancer validation of epigenetic signatures, focusing on DNA methylation patterns.
Epigenetic biomarkers, particularly DNA methylation signatures and cell-free nucleosome profiles, offer immense potential for early disease detection, prognosis, and monitoring therapeutic response.
This article provides a comprehensive, evidence-based analysis of two principal non-invasive screening methodologies for colorectal cancer (CRC): the fecal immunochemical test (FIT) and the blood-based Septin 9 (SEPT9) methylated DNA...
This article provides a comprehensive roadmap for researchers, scientists, and drug development professionals seeking to validate robust biomarkers through multi-omics integration.
This article provides researchers, scientists, and drug development professionals with a detailed analysis of tissue and liquid biopsy-based DNA methylation profiling.
This article provides a comprehensive comparison of DNA methylation and genetic mutation biomarkers for researchers and drug development professionals.
This article provides a comprehensive guide to the critical performance metrics of sensitivity and specificity in the context of epigenetic biomarkers.
This comprehensive guide provides researchers, scientists, and drug development professionals with a detailed roadmap for the pre-analytical phase of epigenetic studies.
This article provides a comprehensive technical guide for researchers and drug development professionals seeking to enhance the reliability of DNA methylation analyses.
This article provides a complete roadmap for researchers and bioinformaticians to identify, correct, and validate batch effects in DNA methylation array data.